Showing results (21-30 of 47) with videos related to
Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|September 5, 2008
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical courseNicole Prada, Brandi Davis, Patrick Jean-Pierre, et al.Frontiers in Immunology|April 27, 2019
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled TrialMansi Saxena, Rachel L Sabado, Melissa La Mar, et al.Antimicrobial Agents and Chemotherapy|December 4, 2023
Molnupiravir maintains antiviral activity against SARS-CoV-2 variants and exhibits a high barrier to the development of resistanceJulie M Strizki, John M Gaspar, John A Howe, et al.Cell Reports|April 9, 2025
Antibody evasiveness of SARS-CoV-2 subvariants KP.3.1.1 and XECQian Wang, Yicheng Guo, Ian A Mellis, et al.Plos Medicine|December 7, 2006
Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infectionSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.Journal of Virology|October 27, 2006
Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infectionSaurabh Mehandru, Michael A Poles, Klara Tenner-Racz, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 28, 2002
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events]Fumio Kodama, Hiroshi Mohri, Shigeki Motomura, et al.Journal of Virology|August 10, 2007
Adjunctive passive immunotherapy in human immunodeficiency virus type 1-infected individuals treated with antiviral therapy during acute and early infectionSaurabh Mehandru, Brigitta Vcelar, Terri Wrin, et al.AIDS (London, England)|December 1, 2016
Cabotegravir long acting injection protects macaques against intravenous challenge with SIVmac251Chasity D Andrews, Leslie St Bernard, Amanda Yee Poon, et al.Science (New York, N.Y.)|March 6, 2014
Long-acting integrase inhibitor protects macaques from intrarectal simian/human immunodeficiency virusChasity D Andrews, William R Spreen, Hiroshi Mohri, et al.Pageof 5